Director of Urologic Trauma, Reconstruction, and Prosthetics, Fox Chase / Einstein Urologic Institute, Einstein Healthcare Network
Urology
Dr. Jay Simhan, MD
|
|
Give Review
Doctor Jay Simhan, MD is an expert in the field of Urology. He went to University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is one of the top medical schools in the US. University of North Carolina at Chapel Hill School of Medicine is ranked 22/2 in Research/PrimaryCare. Jay Simhan, MD is a published doctor. He has 25 papers published. The most current publication "Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database." He accepts all Medicare patients.
Publications
- Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
- Familiarity and Self-Reported Compliance with American Urological Association Best Practice Recommendations for Use of Thromboembolic Prophylaxis among American Urolog...
- Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis.
- Nephron Sparing Management versus Radical Nephroureterectomy for Low or Moderate Grade, Low Stage Upper Tract Urothelial Carcinoma.
- Comparison of Prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care.
- Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment.
- Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
- Trends in Regionalization of Adrenalectomy to Higher Volume Surgical Centers.
- Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009.
- Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells.
- Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity.
- Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L.-Nephrometry Score.
- Perioperative Outcomes of Robotic and Open Partial Nephrectomy for Moderately and Highly Complex Renal Lesions.
- Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass.
- Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant Prostate cancer.
- Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines.
- Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study.
- Delayed proximal ureteric stricture formation after complex partial nephrectomy.
- Clinical stage t1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas.
- Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.
- Intensely positron emission tomography-avid benign adrenal adenoma.
- Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
- Racial differences in hypogonadal improvement and Prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy.
- Prostate-specific antigen changes and Prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Schools
University of North Carolina At Chapel Hill
Procedures Preformed
- Uroflowmetry
Conditions Treated
- Hydronephrosis
- Kidney Stones
- Prostate Cancer
- Ureteral Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Temple University Hospital -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Einstein Medical Center Philadelphia -
Fox Chase Cancer Center-American Oncologic Hospital -
Veterans Affairs North Texas Health Care System
Drug Facts
| NPI NUMBER | 1669613113 | |
| NPPES Provider LastName | SIMHAN | |
| NPPES Provider FirstName | JAY | |
| NPPES Provider ZIPCode | 191413019 | |
| NPPES Provider State | PA | |
| Specialty Description | Urology | |
| Total Claim Count | 103.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 28.0 | |
| Percent Opioid Claims | 27.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669613113 |
| Last Name Of The Provider | SIMHAN |
| First Name Of The Provider | JAY |
| View All |
Similar Doctors
|
|
Dr. Ifeanyichukwu Megwalu, MD |
|
|
Dr. Anton Kapp Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Yew L. Chong, MB BS |
|
|
Dr. Ali Husain, DO |
|
|
Dr. Amar Y. Rawal, MD |
|
|
Dr. Jose M. Reyes, MD |
|
|
Dr. Jeffrey D. Reich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Harris, MD |
|
|
Dr. Joseph F. Harryhill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George W. Drach, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jeanne Llenado, DO |